These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2551389)

  • 21. A search for an 'ouabain-like' substance from the electric organ of Electrophorus electricus which led to arachidonic acid and related fatty acids.
    Bidard JN; Rossi B; Renaud JF; Lazdunski M
    Biochim Biophys Acta; 1984 Jan; 769(1):245-52. PubMed ID: 6318825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N; Lo LC; Berova N; Nakanishi K; Tymiak AA; Ludens JH; Haupert GT
    Biochemistry; 1995 Aug; 34(31):9893-6. PubMed ID: 7632688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solubilization and further chromatographic purification of highly purified, membrane-bound Na,K-ATPase.
    Ottolenghi P; Nørby JG; Jensen J
    Biochem Biophys Res Commun; 1986 Mar; 135(3):1008-14. PubMed ID: 3008735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ; Baecker A; Weiler E; Liddiard C
    Klin Wochenschr; 1986 Aug; 64(16):760-6. PubMed ID: 3020314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T; Tamura M
    Am J Med Sci; 1988 Apr; 295(4):400-5. PubMed ID: 2834953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of digitalis-like factors in human plasma. Interactions with NaK-ATPase and cross-reactivity with cardiac glycoside-specific antibodies.
    Kelly RA; O'Hara DS; Canessa ML; Mitch WE; Smith TW
    J Biol Chem; 1985 Sep; 260(21):11396-405. PubMed ID: 2995332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ouabain-binding site of (Na+ + K+)-ATPase in right-side-out vesicles has not an externally accessible SH group.
    Scheiner-Bobis G; Zimmermann M; Kirch U; Schoner W
    Eur J Biochem; 1987 Jun; 165(3):653-6. PubMed ID: 3036511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Na,K-ATPase inhibitor from guinea pig brain is not ouabain-like.
    Kracke GR
    J Lab Clin Med; 1983 Jan; 101(1):105-13. PubMed ID: 6294201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM
    Clin Exp Hypertens; 1998; 20(5-6):535-42. PubMed ID: 9682909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oleic and linoleic acids are active principles in Nigella sativa and stabilize an E(2)P conformation of the Na,K-ATPase. Fatty acids differentially regulate cardiac glycoside interaction with the pump.
    Mahmmoud YA; Christensen SB
    Biochim Biophys Acta; 2011 Oct; 1808(10):2413-20. PubMed ID: 21767529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides.
    Chiou S; Vesely DL
    Endocrinology; 1995 May; 136(5):2033-9. PubMed ID: 7720651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in renal Na+K+ATPase activity and [3H]ouabain binding in Goldblatt hypertensive rabbits.
    Akabane S; Natsume T; Matsushima Y; Deguchi F; Kuramochi M; Ito K
    J Hypertens; 1985 Oct; 3(5):469-74. PubMed ID: 2415578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of renal Na(+),K(+)-ATPase and ouabain-sensitive H(+),K(+)-ATPase by the cyclic AMP-protein kinase A signal transduction pathway.
    Bełtowski J; Marciniak A; Wójcicka G; Górny D
    Acta Biochim Pol; 2003; 50(1):103-14. PubMed ID: 12673350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ouabain-like factors in human urine: identification of a Na-K-ATPase inhibitor as vanadium-diascorbate adduct.
    Kramer HJ; Krampitz G; Bäcker A; Meyer-Lehnert H
    Clin Exp Hypertens; 1998; 20(5-6):557-71. PubMed ID: 9682912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
    Veklich TO; Shkrabak OA; Kosterin SO; Rodik RV; Cherenok SO; Boĭko SO; Boĭko VI; Kal'chenko VI
    Ukr Biokhim Zh (1999); 2006; 78(6):53-63. PubMed ID: 17494319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascorbic acid: an endogenous inhibitor of isolated Na+,K+-ATPase.
    Ng YC; Akera T; Han CS; Braselton WE; Kennedy RH; Temma K; Brody TM; Sato PH
    Biochem Pharmacol; 1985 Jul; 34(14):2525-30. PubMed ID: 2990490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modifications induced by plasma of gestational hypertensive women on the Na+/K+-ATPase obtained from human placenta.
    Cester N; Rabini RA; Tranquilli AL; Lucarelli G; Salvolini E; Staffolani R; Amler E; Zolese G; Mazzanti L
    Mol Cell Biochem; 1997 May; 170(1-2):125-9. PubMed ID: 9144326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on ouabain-complexed (Na+ +K+)-ATPase carried out with vanadate.
    Hansen O
    Biochim Biophys Acta; 1982 Nov; 692(2):187-95. PubMed ID: 6293562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.